Ivar S Jensen, Joanne Hathway, Philip Cyr, David Gauden, & Peter Gardiner. (2020). Cost-consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer. Taylor & Francis Group.
Chicago Style (17th ed.) CitationIvar S Jensen, Joanne Hathway, Philip Cyr, David Gauden, and Peter Gardiner. Cost-consequence Analysis of 18F-fluciclovine for the Staging of Recurrent Prostate Cancer. Taylor & Francis Group, 2020.
MLA (9th ed.) CitationIvar S Jensen, et al. Cost-consequence Analysis of 18F-fluciclovine for the Staging of Recurrent Prostate Cancer. Taylor & Francis Group, 2020.
Warning: These citations may not always be 100% accurate.